Literature DB >> 24410633

ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Michael F Salvatore1.   

Abstract

Compensatory mechanisms in dopamine (DA) signaling have long been proposed to delay onset of locomotor symptoms during Parkinson's disease progression until ~ 80% loss of striatal DA occurs. Increased striatal dopamine turnover has been proposed to be a part of this compensatory response, but may occur after locomotor symptoms. Increased tyrosine hydroxylase (TH) activity has also been proposed as a mechanism, but the impact of TH protein loss upon site-specific TH phosphorylation in conjunction with the impact on DA tissue content is not known. The tissue content of DA was determined against TH protein loss in the striatum and substantia nigra (SN) following 6-hydroxydopamine lesion in the medial forebrain bundle in young Sprague-Dawley male rats. Although DA predictably decreased in both regions following 6-hydroxydopamine, there was a significant difference in DA loss between the striatum (75%) and SN (40%), despite similar TH protein loss. Paradoxically, there was a significant decrease in DA against remaining TH protein in striatum, but a significant increase in DA against remaining TH in SN. In the SN, increased DA per remaining TH protein was matched by increased ser31, but not ser40, TH phosphorylation. In striatum, both ser31 and ser40 phosphorylation decreased, reflecting decreased DA per TH. However, in control nigral and striatal tissue, only ser31 phosphorylation correlated with DA per TH protein. Combined, these results suggest that the phosphorylation of ser31 in the SN may be a mechanism to increase DA biosynthesis against TH protein loss in an in vivo model of Parkinson's disease. Properties of dopamine biosynthesis were evaluated in the 6-OHDA model of Parkinson's disease by studying the impact of tyrosine hydroxylase (TH) protein loss on its own phosphorylation and dopamine (DA) tissue content in rat nigrostriatal pathway. A dichotomous response was observed between striatum and substantia nigra in that dopamine per remaining TH decreased in striatum, but increased in substantia nigra. Phosphorylation at ser31 reflected these differences, indicating that ser31 phosphorylation may be critical to maintain dopamine with progressive TH protein loss. Drawings are from slides purchased from Motifolio (http://motifolio.com/).
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  6-OHDA; Parkinson's disease; dopamine; nigrostriatal; substantia nigra; tyrosine hydroxylase

Mesh:

Substances:

Year:  2014        PMID: 24410633      PMCID: PMC3997657          DOI: 10.1111/jnc.12652

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  71 in total

1.  Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.

Authors:  Ignacio Cruz-Muros; Domingo Afonso-Oramas; Pedro Abreu; Pedro Barroso-Chinea; Manuel Rodríguez; M Carmen González; Tomás González Hernández
Journal:  Exp Neurol       Date:  2006-11-16       Impact factor: 5.330

2.  Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.

Authors:  Daniel R Andersson; Hans Nissbrandt; Filip Bergquist
Journal:  Eur J Neurosci       Date:  2006-07       Impact factor: 3.386

3.  Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.

Authors:  Timothy J Collier; Jack Lipton; Brian F Daley; Stephane Palfi; Yaping Chu; Caryl Sortwell; Roy A E Bakay; John R Sladek; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2007-01-23       Impact factor: 5.996

4.  Subthalamic stimulation increases striatal tyrosine hydroxylase phosphorylation.

Authors:  Rene Reese; Christine Winter; Agnes Nadjar; Daniel Harnack; Rudolf Morgenstern; Andreas Kupsch; Erwan Bezard; Wassilios Meissner
Journal:  Neuroreport       Date:  2008-01-22       Impact factor: 1.837

5.  Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.

Authors:  Michael F Salvatore; Brent Fisher; Stewart P Surgener; Greg A Gerhardt; Tracey Rouault
Journal:  Brain Res Mol Brain Res       Date:  2005-10-03

6.  Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.

Authors:  Christian Pifl; Oleh Hornykiewicz
Journal:  Neurochem Int       Date:  2006-05-15       Impact factor: 3.921

Review 7.  Tyrosine hydroxylase phosphorylation: regulation and consequences.

Authors:  Peter R Dunkley; Larisa Bobrovskaya; Mark E Graham; Ellak I von Nagy-Felsobuki; Phillip W Dickson
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

Review 8.  Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.

Authors:  T Nagatsu; M Sawada
Journal:  J Neural Transm Suppl       Date:  2007

9.  Morphometry of the human substantia nigra in ageing and Parkinson's disease.

Authors:  Gay Rudow; Richard O'Brien; Alena V Savonenko; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Laura Marsh; Ted M Dawson; Barbara J Crain; Mark J West; Juan C Troncoso
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

10.  Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.

Authors:  Eva Lin; Jane E Cavanaugh; Rehana K Leak; Ruth G Perez; Michael J Zigmond
Journal:  J Neurosci Res       Date:  2008-01       Impact factor: 4.164

View more
  20 in total

1.  Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Authors:  Tanya Chotibut; Samantha Meadows; Ella A Kasanga; Tamara McInnis; Mark A Cantu; Christopher Bishop; Michael F Salvatore
Journal:  Mov Disord       Date:  2017-06-20       Impact factor: 10.338

2.  Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

Authors:  Ana Jorge-Finnigan; Rune Kleppe; Kunwar Jung-Kc; Ming Ying; Michael Marie; Ivan Rios-Mondragon; Michael F Salvatore; Jaakko Saraste; Aurora Martinez
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

3.  Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention.

Authors:  Michael F Salvatore; Jennifer Terrebonne; Mark A Cantu; Tamara R McInnis; Katy Venable; Parker Kelley; Ella A Kasanga; Brian Latimer; Catherine L Owens; Brandon S Pruett; Yongmei Yu; Robert Luedtke; Michael J Forster; Nathalie Sumien; Donald K Ingram
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-12-12       Impact factor: 6.053

4.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

5.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

6.  Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Authors:  Michael F Salvatore; Vicki A Nejtek; Habibeh Khoshbouei
Journal:  Neurotoxicology       Date:  2018-05-18       Impact factor: 4.294

7.  Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.

Authors:  Jennifer C Arnold; Michael F Salvatore
Journal:  ACS Chem Neurosci       Date:  2015-12-08       Impact factor: 4.418

8.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

9.  Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents.

Authors:  Natalie S McGuier; Jennifer A Rinker; Reginald Cannady; Diana B Fulmer; Sara R Jones; Michaela Hoffman; Patrick J Mulholland
Journal:  Neuropharmacology       Date:  2018-05-25       Impact factor: 5.250

10.  Dopamine Synthesis as a Mechanism of Brain Plasticity in Nigrostriatal System Pathology.

Authors:  A A Kolacheva; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2018-05-19       Impact factor: 0.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.